{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:00:54Z","timestamp":1785513654367,"version":"3.56.0"},"reference-count":38,"publisher":"Akademiai Kiado Zrt.","issue":"28","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2026,7,12]]},"abstract":"Esettanulm\u00e1nyunkban posztoperat\u00edv maculaoedem\u00e1ban szenved\u0151 beteg t\u00falnyom\u00e1sos\n (hiperb\u00e1rikus) oxig\u00e9nter\u00e1pi\u00e1val (HBOT) kieg\u00e9sz\u00edtett kezel\u00e9s\u00e9t mutatjuk be.\n Vizsg\u00e1latunk c\u00e9lja a HBOT potenci\u00e1lis ter\u00e1pi\u00e1s hat\u00e9konys\u00e1g\u00e1nak \u00e9rt\u00e9kel\u00e9se volt a\n m\u0171t\u00e9t ut\u00e1ni maculaoedema gy\u00f3gyul\u00e1si folyamat\u00e1nak gyors\u00edt\u00e1s\u00e1ban. 58 \u00e9ves,\n eg\u00e9szs\u00e9ges f\u00e9rfi betegn\u00e9l bal oldali multifok\u00e1lis m\u0171lencse be\u00fcltet\u00e9s\u00e9vel j\u00e1r\u00f3\n phacoemulsifikati\u00f3s m\u0171t\u00e9t ut\u00e1ni h\u00e9ten zavar\u00f3 hom\u00e1lyos l\u00e1t\u00e1s alakult ki, tiszta\n t\u00f6r\u0151k\u00f6zegek mellett. A bevezetett standard ter\u00e1pia (topik\u00e1lis kortikoszteroid \u00e9s\n nemszteroid gyullad\u00e1scs\u00f6kkent\u0151 \u2013 NSAID) alkalmaz\u00e1sa mellett a t\u00fcnet perziszt\u00e1lt,\n a beteg centr\u00e1lisretina-vastags\u00e1ga a posztoperat\u00edv 35. napon 327 \u03bcm,\n l\u00e1t\u00e1s\u00e9less\u00e9ge 0,4 volt. Ekkor a szem\u00e9szeti konzervat\u00edv ter\u00e1pi\u00e1t folytatva,\n kieg\u00e9sz\u00edt\u0151 HBOT-k\u00far\u00e1t ind\u00edtottunk, \u00f6sszesen 11 alkalom, 2,5 ATA\/90 perc, 100%-os\n oxig\u00e9n l\u00e9gz\u00e9se, 20\/5 leveg\u0151sz\u00fcnet protokollal. A beteg a negyedik HBOT-kezel\u00e9st\n k\u00f6vet\u0151en soron k\u00edv\u00fcli kontrollvizsg\u00e1latra jelentkezett, szubjekt\u00edv hom\u00e1lyos\n l\u00e1t\u00e1si panaszai jelent\u0151sen cs\u00f6kkentek. Ezen vizsg\u00e1lat alkalm\u00e1val a l\u00e1t\u00e1s\u00e9less\u00e9ge\n 0,9-re javult. A HBOT-kezel\u00e9st a nagyfok\u00fa \u00e9s gyors t\u00fcnetregresszi\u00f3 ellen\u00e9re\n folytattuk az eredm\u00e9ny megtart\u00e1sa \u00e9s a neuroplaszticit\u00e1s, az agyi akkomod\u00e1ci\u00f3\n facilit\u00e1l\u00e1sa \u00e9rdek\u00e9ben. A z\u00e1r\u00f3 OCT- (optikaikoherencia-tomogr\u00e1fi\u00e1s) vizsg\u00e1lat a\n HBOT-k\u00fara ut\u00e1n egy h\u00f3nappal t\u00f6rt\u00e9nt: l\u00e1t\u00f3\u00e9less\u00e9ge 1,0, a macula vastags\u00e1ga 267\n \u03bcm volt. Hiperb\u00e1rikus oxig\u00e9nter\u00e1pia mellett a posztoperat\u00edv maculaoedema okozta\n hom\u00e1lyos l\u00e1t\u00e1si t\u00fcnet regresszi\u00f3ja jelent\u0151sen felgyorsult, az eredm\u00e9nyt\n OCT-vizsg\u00e1lattal objektiviz\u00e1ltuk, amely nem magyar\u00e1zhat\u00f3 spont\u00e1n javul\u00e1ssal. Az\n ilyen etiol\u00f3gi\u00e1j\u00fa maculaoedema-kezel\u00e9sben a HBOT alkalmaz\u00e1sa jelent\u0151s\n \u00e9letmin\u0151s\u00e9g-javul\u00e1st jelenthet azokban az esetekben, amelyekn\u00e9l a szubjekt\u00edv\n meg\u00e9l\u00e9s vagy a gy\u00f3gyul\u00e1s id\u0151faktora jelent\u0151s t\u00e9nyez\u0151. Orv Hetil. 2026; 167(28):\n 1120\u20131126.<\/jats:p>","DOI":"10.1556\/650.2026.33555","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:02:12Z","timestamp":1783933332000},"page":"1120-1126","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["M\u0171t\u00e9t ut\u00e1ni maculaoedema gy\u00f3gyul\u00e1s\u00e1nak gyors\u00edt\u00e1sa t\u00falnyom\u00e1sos (hiperb\u00e1rikus) oxig\u00e9nter\u00e1pi\u00e1s m\u00f3dszerrel"],"prefix":"10.1556","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7330-0464","authenticated-orcid":true,"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika Budapest, M\u00e1ria u. 39., 1085 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist\u00f3f M\u00e1rton","family":"V\u00f6r\u00f6s","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika Budapest, M\u00e1ria u. 39., 1085 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Dorm\u00e1n","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika Budapest, M\u00e1ria u. 39., 1085 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolett","family":"Szolnoki","sequence":"additional","affiliation":[{"name":"Balance Medical Center Lenti Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Efrati S, Fishlev G, Bechor Y, et al. Hyperbaric oxygen induces late\n neuroplasticity in post stroke patients - randomized, prospective trial. PLOS\n ONE 2013; 8: e53716.\n https:\/\/doi.org\/10.1371\/journal.pone.0053716","DOI":"10.1371\/journal.pone.0053716"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Henderson BA, Kim JY, Ament CS, et al. Clinical pseudophakic cystoid\n macular edema. Risk factors for development and duration after treatment. J\n Cataract Refract Surg. 2007; 33: 1550-1558.\n https:\/\/doi.org\/10.1016\/j.jcrs.2007.05.013","DOI":"10.1016\/j.jcrs.2007.05.013"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Loewenstein A, Zur D. Postsurgical cystoid macular edema. Dev\n Ophthalmol. 2010; 47: 148-159.\n https:\/\/doi.org\/10.1159\/000320078","DOI":"10.1159\/000320078"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Luk\u00e1cs M\u00c1, M\u00f3dis L. Anterior segment optical coherence tomography in\n modern ophthalmic diagnostics. [El\u00fcls\u0151szegmentum-optikaikoherencia-tomogr\u00e1fia\n (OCT) a korszer\u0171 szem\u00e9szeti diagnosztik\u00e1ban.] Orv Hetil. 2024; 165: 1112-1121.\n [Hungarian] https:\/\/doi.org\/10.1556\/650.2024.33085","DOI":"10.1556\/650.2024.33085"},{"key":"R5","unstructured":"Flach AJ. The incidence, pathogenesis and treatment of cystoid\n macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998; 96:\n 557-634."},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Benitah NR, Arroyo JG. Pseudophakic cystoid macular edema. Int\n Ophthalmol Clin. 2010; 50: 139-153.\n https:\/\/doi.org\/10.1097\/IIO.0b013e3181c551da","DOI":"10.1097\/IIO.0b013e3181c551da"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Elekes \u00c1, V\u00e1mosi P. On the toxicity of intracameral cefuroxime\n administration. [Az intracameralis cefuroxim toxicit\u00e1s\u00e1r\u00f3l.] Orv Hetil. 2025;\n 166: 301-306. [Hungarian]","DOI":"10.1556\/650.2025.33245"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Rashid S, Young LH. Progression of diabetic retinopathy and\n maculopathy after phacoemulsification surgery. Int Ophthalmol Clin. 2010; 50:\n 155-166.\n https:\/\/doi.org\/10.1097\/IIO.0b013e3181c555cf","DOI":"10.1097\/IIO.0b013e3181c555cf"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"B\u00e9lair ML, Kim SJ, Thorne JE, et al. Incidence of cystoid macular\n edema after cataract surgery in patients with and without uveitis using optical\n coherence tomography. Am J Ophthalmol. 2009; 148: 128-135. e2.\n https:\/\/doi.org\/10.1016\/j.ajo.2009.02.029","DOI":"10.1016\/j.ajo.2009.02.029"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Miyake K, Ibaraki N, Goto Y, et al. ESCRS Binkhorst lecture 2002:\n Pseudophakic preservative maculopathy. J Cataract Refract Surg. 2003; 29:\n 1800-1810.\n https:\/\/doi.org\/10.1016\/S0886-3350(03)00560-1","DOI":"10.1016\/S0886-3350(03)00560-1"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"London NJ, Chiang A, Haller JA. The dexamethasone drug delivery\n system: indications and evidence. Adv Ther. 2011; 28: 351-366. Erratum: Adv\n Ther. 2013; 30: 644.\n https:\/\/doi.org\/10.1007\/s12325-011-0019-z","DOI":"10.1007\/s12325-011-0019-z"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Orski M, Gaw\u0119cki M. Current management options in Irvine-Gass\n syndrome: a systemized review. J Clin Med. 2021; 10: 4375.\n https:\/\/doi.org\/10.3390\/jcm10194375","DOI":"10.3390\/jcm10194375"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Katzen LE, Fleischman JA, Trokel S. YAG laser treatment of cystoid\n macular edema. Am J Ophthalmol. 1983; 95: 589-592.\n https:\/\/doi.org\/10.1016\/0002-9394(83)90375-6","DOI":"10.1016\/0002-9394(83)90375-6"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Ferro Desideri L, Arun K, Bernardi E, et al. Incidence,\n pathogenesis, risk factors and treatment of cystoid macular edema following\n cataract surgery: a systematic review. Diagnostics (Basel) 2025; 10: 667.\n https:\/\/doi.org\/10.3390\/diagnostics15060667","DOI":"10.3390\/diagnostics15060667"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Govetto A, Francone A, Lucchini S, et al. Microcystoid macular edema\n in epiretinal membrane: not a retrograde maculopathy. Am J Ophthalmol. 2025;\n 272: 48-57.\n https:\/\/doi.org\/10.1016\/j.ajo.2024.12.027","DOI":"10.1016\/j.ajo.2024.12.027"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Yuksel Elgin C, Kaner Savci I, Birisik Y, et al. Investigating clues\n of cystoid macular edema from a vascular perspective under long-term latanoprost\n usage. Int Ophthalmol. 2025; 10: 188.\n https:\/\/doi.org\/10.1007\/s10792-025-03556-9","DOI":"10.1007\/s10792-025-03556-9"},{"key":"R17","unstructured":"Moon RE. Handbook on hyperbaric medicine. 14th ed. Undersea and\n Hyperbaric Medical Society, Best Publishing Company, North Palm Beach, Florida,\n FL, 2019."},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules\n 2020; 10: 958. https:\/\/doi.org\/10.3390\/biom10060958","DOI":"10.3390\/biom10060958"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Mathieu D. (ed.) Handbook on hyperbaric medicine. Springer,\n Dordrecht, 2006.\n https:\/\/doi.org\/10.1007\/1-4020-4448-8","DOI":"10.1007\/1-4020-4448-8"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Thom SR, Bhopale VM, Velazquez OC, et al. Stem cell mobilization by\n hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006; 290: 1378-1386.\n https:\/\/doi.org\/10.1152\/ajpheart.00888.2005","DOI":"10.1152\/ajpheart.00888.2005"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Correction to Mathieu D, Marroni A, Kot J, et al. Tenth European\n Consensus Conference on Hyperbaric Medicine: recommendations for accepted and\n non-accepted clinical indications and practice of hyperbaric oxygen treatment.\n Diving Hyperb Med. 2017; 47: 24-32. Diving Hyperb Med. 2017; 47: 131-132.\n https:\/\/doi.org\/10.28920\/dhm47.1.24-32","DOI":"10.28920\/dhm47.1.24-32"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Sayin O, Altinkaynak H. The effects of hyperbaric oxygen therapy on\n retinal layers in healthy eyes. Undersea Hyperb Med. 2022; 49: 485-494.\n https:\/\/doi.org\/10.22462\/07.08.2022.8","DOI":"10.22462\/07.08.2022.8"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"\u00c7evik SG, Ba\u011fl\u0131 BS. Change in the foveal avascular zone and macular\n capillary network density after hyperbaric oxygen therapy in healthy retina. J\n Ophthalmic Vis Res. 2021; 16: 393-399.\n https:\/\/doi.org\/10.18502\/jovr.v16i3.9436","DOI":"10.18502\/jovr.v16i3.9436"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Dikmen NT, Akyol UC, Comerter D, et al. The effect of hyperbaric\n oxygen therapy on retina, choroidal thickness, and choroidal vascularity index.\n Photodiagn Photodyn Ther. 2022; 38: 102854.\n https:\/\/doi.org\/10.1016\/j.pdpdt.2022.102854","DOI":"10.1016\/j.pdpdt.2022.102854"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Lo WJ, Lin YC, Chang HY, et al. Risk factors for ocular\n neovascularization after central retinal artery occlusion. J Chin Med Assoc.\n 2022; 85: 880-885.\n https:\/\/doi.org\/10.1097\/JCMA.0000000000000766","DOI":"10.1097\/JCMA.0000000000000766"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual\n outcome. Am J Ophthalmol. 2005; 140: 376-391.\n https:\/\/doi.org\/10.1016\/j.ajo.2005.03.038","DOI":"10.1016\/j.ajo.2005.03.038"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Kiryu J, Ogura Y. Hyperbaric oxygen treatment for macular edema in\n retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica\n 1996; 210: 168-170.\n https:\/\/doi.org\/10.1159\/000310700","DOI":"10.1159\/000310700"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Chang YH, Chen PL, Tai MC, et al. Hyperbaric oxygen therapy\n ameliorates the blood-retinal barrier breakdown in diabetic retinopathy. Clin\n Exp Ophthalmol. 2006; 34: 584-589.\n https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01280.x","DOI":"10.1111\/j.1442-9071.2006.01280.x"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Maalej A, Khallouli A, Choura R, et al. The effects of hyperbaric\n oxygen therapy on diabetic retinopathy: a preliminary study. J Fr Ophthalmol.\n 2020; 43: 133-138.\n https:\/\/doi.org\/10.1016\/j.jfo.2019.07.005","DOI":"10.1016\/j.jfo.2019.07.005"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Kald\u0131r\u0131m H, Yazgan S, Ceylan B, et al. The effect of hyperbaric\n oxygen therapy on retinal thickness and progression of retinopathy in patients\n with Type 2 diabetes: a prospective cohort study. Cutan Ocul Toxicol. 2019; 38:\n 233-239.\n https:\/\/doi.org\/10.1080\/15569527.2019.1608226","DOI":"10.1080\/15569527.2019.1608226"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Sellman A, Katzman P, Andreasson S, et al. Long-term effects of\n hyperbaric oxygen therapy on visual acuity and retinopathy. Undersea Hyperb Med.\n 2020; 47: 423-430.\n https:\/\/doi.org\/10.22462\/03.07.2020.3","DOI":"10.22462\/03.07.2020.3"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"G\u00fcn RD, G\u00fcm\u00fc\u015f T, Karda\u015f AS, et al. Acute effect of hyperbaric oxygen\n therapy on macular and choroidal thickness in patients with type 2 diabetes and\n diabetic foot ulcers: optical coherence tomography-based study. Photodiagnosis\n Photodyn Ther. 2022; 39: 102926.\n https:\/\/doi.org\/10.1016\/j.pdpdt.2022.102926","DOI":"10.1016\/j.pdpdt.2022.102926"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Malik A, Golnik K. Hyperbaric oxygen therapy in the treatment of\n radiation optic neuropathy. J Neuroophthalmol. 2012; 32: 128-131.\n https:\/\/doi.org\/10.1097\/WNO.0b013e3182464c88","DOI":"10.1097\/WNO.0b013e3182464c88"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Hsieh YH, Liang CM, Tai MC, et al. Benefit of hyperbaric oxygen\n therapy treatment in direct traumatic optic neuropathy: case report. Undersea\n Hyperb Med. 2018; 45: 463-471.\n https:\/\/doi.org\/10.22462\/07.08.2018.12","DOI":"10.22462\/07.08.2018.12"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Alexander JL, Shulman MD, Sethuraman K. Acute direct traumatic optic\n neuropathy treated with steroids, minocycline and hyperbaric oxygen: a case\n report. Undersea Hyperb Med. 2019; 46: 709-712.\n https:\/\/doi.org\/10.22462\/10.12.2019.17","DOI":"10.22462\/10.12.2019.17"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Allashem HM, Sward DG, Sethuraman K, et al. Hyperbaric oxygen\n therapy for perioperative posterior ischemic optic neuropathy: a case report.\n Undersea Hyperb Med. 2019; 46: 701-707.\n https:\/\/doi.org\/10.22462\/10.12.2019.16","DOI":"10.22462\/10.12.2019.16"},{"key":"R37","unstructured":"Malerbi FK, Novais EA, Emmerson B, et al. Hyperbaric oxygen therapy\n for choroidal neovascularization: a pilot study. Undersea Hyperb Med. 2015; 42:\n 125-131."},{"key":"R38","unstructured":"Butler FK Jr., Hagan C, Murphy-Lavoie H, et al. Hyperbaric oxygen\n therapy and the eye. Undersea Hyperb Med. 2008; 35: 333-387."}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/167\/28\/article-p1120.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/167\/28\/article-p1120.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/167\/28\/article-p1120.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:22:14Z","timestamp":1785511334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/167\/28\/article-p1120.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":38,"journal-issue":{"issue":"28"},"URL":"https:\/\/doi.org\/10.1556\/650.2026.33555","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]}}}